HIGHLIGHTS
- who: Xiaojing Xu from the Department Soochow University, Suzhou, People's Republic of China have published the paper: Tumor Cells Modified with Newcastle Disease Virus Expressing IL-24 as a Cancer Vaccine, in the Journal: (JOURNAL) of 14/09/2019
- what: In the present work, IL-24 were inserted between P and M, and the insertion did not affect the replication of recombinant virus, as compared with the parental strain.
- how: The results showed that B16-LX/IL-24 could not provide any increased preventive effects against EL-4 cells as compared with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.